RUPERT VESSEY Insider Trading
Get free email notifications about insider trading for RUPERT VESSEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RUPERT VESSEY. RUPERT VESSEY is a EVP, Research & Early Dev. in BRISTOL MYERS SQUIBB CO ($BMY) and a Pres., Research & Early Dev. in BRISTOL MYERS SQUIBB CO ($BMY) and a PRES., RESEARCH AND EARLY DEV. in CELGENE CORP /DE/ ($CELG) and a See remarks in CELGENE CORP /DE/ ($CELG) and a in BIO-TECHNE Corp ($TECH) and a Director in BIO-TECHNE Corp ($TECH).
Address: C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT 07901 NJ
Companies in which RUPERT VESSEY is an Insider
BIO-TECHNE Corp
Trading Symbol: TECHIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RUPERT VESSEY:
Holdings: 1,033 shares
Current Value: $104,519
Latest Transaction: Nov 02 2020
$TECH Market Capitalization: $3.73B
$TECH Previous Close: $101.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BRISTOL MYERS SQUIBB CO
Trading Symbol: BMYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RUPERT VESSEY: EVP, Research & Early Dev., Pres., Research & Early Dev.
Holdings: 62,384 shares
Current Value: $3,222,757
Latest Transaction: May 11 2021
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CELGENE CORP /DE/
Trading Symbol: CELGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RUPERT VESSEY: PRES., RESEARCH AND EARLY DEV., See remarks
Holdings: 22,812 shares
Current Value: $2,652,123
Latest Transaction: Nov 22 2019
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of RUPERT VESSEY
Sentiment: All, TECH, BMY, CELG
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Option Exercise | M | 0.00 | 17,245 | 0 | 0 | |
May 11 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Payment of Exercise | F | 64.44 | 7,994 | 515,133 | 54,390 | 62.4 K to 54.4 K (-12.81 %) |
May 11 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Buy | M | 0.00 | 17,245 | 0 | 62,384 | 45.1 K to 62.4 K (+38.20 %) |
May 07 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Sell | S | 64.29 | 30,546 | 1,963,802 | 45,139 | 75.7 K to 45.1 K (-40.36 %) |
Mar 12 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Option Exercise | A | 0.00 | 46,949 | 0 | 46,949 | |
Mar 12 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Option Exercise | A | 0.00 | 31,299 | 0 | 31,299 | |
Mar 12 2021 | BMY | BRISTOL MYERS SQUI ... | VESSEY RUPERT | EVP, Research & Ear ... | Option Exercise | M | 0.00 | 7,423 | 0 | 22,271 |